« Return to News | Awards & Advancement

inVentive Health names president for Europe and executive VP for Asia

Tuesday, October 1, 2013 12:00 PM

Global CRO inVentiv Health has created two new positions to lead its business in Europe and Asia.

Dan Feldman, who established and led inVentiv’s operation in Japan, will take on the new position of president of inVentiv Health Europe. The position will oversee the growth of business across all inVentiv Health segments—clinical research, commercialization and consulting—and will lead development of inVentiv’s approach to convergent services. 

Stephen J. Walter will join the company as executive vice president for Asia. Walter formerly was managing director for Merck Sharpe & Dhome in Vietnam and Cambodia. Previously, he worked as general manager and vice president of consulting and services for IMS Health, based in Singapore. For Bristol-Myers Squibb, he helped launch Entecavir in the Asia Pacific region and was then regional director of business development.

Walter will oversee growth and management of all inVentiv Health business throughout the region, including the expansion of inVentiv’s clinical research capabilities in China. 

Walter, who will be based in Shanghai, will oversee inVentiv operations in the ASEAN nations, Australia and New Zealand, in addition to China and Korea.  He also will assume responsibility for Japan at the end of this year, when he takes the reins from Feldman.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.